Irvine Pharma Building CRO/CMO Facility in Hangzhou

Irvine Pharmaceutical Services, a California company offering cGMP contract development and parenteral manufacturing services, announced plans to open a new facility in Hangzhou, China. This newly built, state-of-the-art facility will encompass 115,000 square feet of floor space, and bring Irvine's service offerings into Asian markets. The company expects the plant to be fully operational in early 2015. More details.... Share this with colleagues: // //